Table 1.
Characteristics of subjects
| N | 17 |
| Sex (male/female) | 14/3 |
| Age (years) | 54.6 ± 14.6 |
| BMI (kg/m2) | 30 ± 5.5 |
| Waist circumference (cm) | 101 ± 11 |
| Visceral fat area (cm2) | 177 ± 67 |
| Subcutaneous fat area (cm2) | 245 ± 131 |
| Adiponectin (μg/mL) | 4.2 ± 1.7 |
| Systolic blood pressure (mm Hg) | 132 ± 17 |
| Diastolic blood pressure (mm Hg) | 82 ± 13.7 |
| Fast plasma glucose (mg/dL) | 102 ± 21 |
| Hemoglobin A1c (%) | 6.3 ± 1.3 |
| Diagnosis (T2DM/B/N) | 5/6/6 |
| HOMA-IR | 3.2 ± 2.3 |
| Total cholesterol (mg/dL) | 206 ± 40 |
| Triglyceride (mg/dL) | 196 ± 129 |
| HDL-C (mg/dL) | 56.3 ± 18.1 |
| LDL-C (mg/dL) | 114 ± 40 |
| Uric acid (mg/dL) | 6.4 ± 0.8 |
| Urinary albumin (μg/day) | 12.3 ± 10.6 |
| eGFR (mL/min/1.73 m2) | 77.9 ± 19.8 |
| mean IMT ≥1.1 mm | 7/10 |
| Statin use (±) | 7/10 |
| ACE-I/ARB use (±) | 4/13 |
Data are mean ± SD
T2DM type 2 diabetes mellitus, B borderline diabetes, N normal glucose tolerance, HOMA-IR homeostasis model assessment of insulin resistance, HDL-C high density lipoprotein-cholesterol, LDL-C low density lipoprotein-cholesterol, eGFR estimated glomerular filtration rate, IMT intima-media thickness, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker